N,N-Dimethyl-1-(piperidin-3-yl)methanamine dihydrochloride, 98+%, 100mg

(2R,3R)-2-(2,4-DIFLUOROPHENYL)-1-(1H-1,2,4-TRIAZOL-1-YL)-2,3-BUTANEDIOL, 95.0%, 1g

2-Chloro-4-fluoronicotinonitrile, 95.0%, 10g

Oxion Inverso OX.2003-PLPH con obiettivi LWD Plan fase 10x/20x/40x

(4-Chloronaphthalen-1-yl)boronic acid, 97.0%, 5g

Imbuti, 30 mm, 1,5 mm, 1 pezzo

4-(2-METHYL-1H-IMIDAZOL-1-YL)PHENOL, 95.0%, 250mg

2-Bromo-5-phenyl-1,3-oxazole, 95.0%, 250mg

Methyl 2,6-dichloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 95.0%, 250mg

1-Chloro-isoquinoline-6-boronic acid, 95+%, 1g

6-BROMO-2-METHYLPYRAZOLO[1,5-A]PYRIMIDINE, 97.0%, 5g

3,3-Difluorocyclobutanamine Hydrochloride>98.0%(T)200mg

tert-Butyl 5-Amino-1H-indazole-1-carboxylate, 97.0%, 250mg